STOCK TITAN

[SCHEDULE 13G/A] Rani Therapeutics Holdings, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: All ownership percentages set forth in this Schedule 13G are calculated based upon an aggregate of 43,606,522 shares of Class A Common Stock outstanding.


SCHEDULE 13G



Orca Capital AG
Signature:/s/ Thomas Konig
Name/Title:Thomas Konig/Director
Date:07/23/2025